NICE has published draft guidance for public consultation which does not recommed tucatinib, in combination with trastuzumab and capecitabine, for some types of breast cancer. Tucatinib is licenced for treating HER2-positive (human epidermal growth factor […]
DNAe, alongside Imperial College London, has been awarded a UK Knowledge Transfer Partnership (KTP) by Innovate UK to collaborate on the early detection of recurrent breast cancer. The programme will support the development of a […]
Merck, known as MSD outside the United States and Canada, announced positive top-line results from two pivotal phase 3 trials of the investigational, once-daily oral fixed dose combination pill of doravirine/islatravir (DOR/ISL) in adults with […]
Flexible packaging company PAC Machinery has designed and developed a new option for its Rollbag automatic baggers, including the Rollbag R785 all-electric automatic bagger. The easy touch start sensor features a magnetic base that enables […]
Johnson & Johnson (J&J) will resume Covid-19 vaccine roll-out in Europe following the European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee (PRAC), which confirmed the overall benefit-risk profile being positive. Johnson & Johnson (J&J) will […]